Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion type Assertion NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_head.
- NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion description "[Furthermore, although the carriage rate of IL1RN*2 was higher in HSPN (46.5%) than average IgAN patients (26.8%; P < 0.01), there was no significant difference in the carriage rate of IL1RN*2 between HSPN and those IgAN patients with recurrent gross hematuria (42.8%l P > 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_provenance.
- NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion evidence source_evidence_literature NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_provenance.
- NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion SIO_000772 9186886 NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_provenance.
- NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion wasDerivedFrom befree-20140225 NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_provenance.
- NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_assertion wasGeneratedBy ECO_0000203 NP666875.RAxCnmK4oV7EAj9q2hGmPwJKHOa8ycbFG1msa5yudQRjQ130_provenance.